● paper signal · live  ·  Nasdaq-100  · 
21.4%
One dollar in the Nasdaq-100 since 1995. Verdant compounded at 21.4% a year versus 14.6% for buy & hold. Same index, smarter exposure.
Verdant CAGR · NDX
21.4%
Buy & hold
14.6%
Edge / year
+5.7pp
Years beating B&H
23 / 32
scroll
The thesis

Outperform the index.

Verdant turns the indices you already trust into a disciplined, self adjusting engine. No forecasts, no narratives, no guesswork. Just a systematic edge, compounding quietly across three decades and 21 global markets.

engaged defensive signal
presses the advantage when conditions favor it steps back as risk rises
Mechanism

Always reading
the market.

Verdant’s exposure is never static. A proprietary signal reads the market in real time and continuously decides how hard your capital should work. Always on, fully systematic, zero discretion.

100% systematic
The edge

More upside.
Comparable downside.

More of the upside. A fraction of the worry. Verdant’s edge compounds quietly, capturing the market’s strongest stretches while holding risk in the same range as simply owning the index. The how is proprietary. The result is on this page.

Verdant drawdown Buy & hold drawdown
The evidence

20 of 21 markets beat buy & hold.

Each dot is an index. Above the line, Verdant wins. Dot size is cumulative excess return. One fixed rule, applied across every market with no tuning. Hover any market.

● labelled dots = core working set (DJI · GSPC · IXIC · NDX)
32 years · Nasdaq-100

Ahead in 23 of 32 years.

Year by year, Verdant’s edge over buy & hold, reaching +52pp in its strongest year. Consistent outperformance, compounding across three decades.

Live dashboard · members only

Every market, up to date.

Explore three decades of results across markets and risk profiles. Sign in to reveal live exposure and the full signal set.

Verdant buy & hold Nasdaq-100
MarketVerdant CAGRB&Hvs B&H Yrs beatLive exposure
Members only

See the live signal.

Sign in to unlock live exposure and the full signal set across every market and risk profile.